Gaia, Inc. (GAIA) formed multiple top with $12.51 target or 3.00% above today’s $12.15 share price. Gaia, Inc. (GAIA) has $184.29 million valuation. The stock increased 2.10% or $0.25 during the last trading session, reaching $12.15. About 20,974 shares traded. Gaia, Inc. (NASDAQ:GAIA) has risen 39.47% since January 5, 2017 and is uptrending. It has outperformed by 22.77% the S&P500.
WINDTREE THERAPEUTICS INCORPORATED (NASDAQ:WINT) had a decrease of 42.08% in short interest. WINT’s SI was 53,400 shares in January as released by FINRA. Its down 42.08% from 92,200 shares previously. With 86,200 avg volume, 1 days are for WINDTREE THERAPEUTICS INCORPORATED (NASDAQ:WINT)’s short sellers to cover WINT’s short positions. The stock decreased 8.29% or $0.0236 during the last trading session, reaching $0.2612. About shares traded. Windtree Therapeutics, Inc. (NASDAQ:WINT) has 0.00% since January 5, 2017 and is . It has underperformed by 16.70% the S&P500.
Windtree Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel surfactant therapies for respiratory diseases and other potential applications. The company has market cap of $16.51 million. The Company’s proprietary technology platform includes a synthetic peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. It currently has negative earnings. The companyÂ’s lead development program comprises AEROSURF, a drug/device product that is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants.